Vericel

VCEL | NASDAQ | 0 Followers
$40.17 +1.93% $0.76
Follow
Overview Metrics Financials
Loading...

Fair Price

$92.08
Overvalued by 21.4%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Vericel Corporation is a biotechnology company that specializes in the development and commercialization of advanced therapies for tissue regeneration. The company primarily focuses on treating severe wounds, burns, and orthopedic conditions, offering autologous cell therapies that use a patient’s own cells to support healing and regeneration. Its key products include Epicel, a therapy for burn treatment, and Carticel, a cell therapy for cartilage repair.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade